Insights from 2023 ESMO Annual Meeting

 

Insights from 2023 ESMO Annual Meeting
Avatar

ESMO 2023 Insights: "Adagrasib +/- Cetuximab in Patients With KRASG12Cm CRC - Analysis of Tumor Biomarkers and Genomic Alterations"

By Insights from 2023 ESMO Annual Meeting FEATURING Meredith Pelster
By Insights from 2023 ESMO Annual Meeting FEATURING Meredith Pelster
71 views
October 26, 2023
0 Comments
Login to view comments. Click here to Login
Gastrointestinal
06:40
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "CHAPTER-GIST-101 Study of Pimitespib Combi…

Feat. Y. Naito
23:27
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "GI Key Studies Including MATTERHORN & K…

Feat. R. Kim, R. Mehta
15:47
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Adjuvant Therapy for CRC Patients"

Feat. C. Cremolini
20:44
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Upper GI Cancers"

Feat. S. Cytryn, F. Pietrantonio, G. Argiles Martinez
17:24
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Lower GI Cancers"

Feat. S. Cytryn, F. Pietrantonio, G. Argiles Martinez
04:01
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "PEVOsq Basket Trial Evaluating the Efficac…

Feat. C. Coutzac
13:35
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Gastrointestinal Tumors - Lower Digestive U…

Feat. R. Dienstmann
07:12
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Nivo + Low Dose Ipi as 1L Therapy in Advan…

Feat. K. Muro
05:36
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The DEEPER Trial - m-FOLFOXIRI + Cetuximab…

Feat. Y. Sunakawa
17:08
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "KEYNOTE-177 5-year Follow-up - Pembro vs. …

Feat. K. Shiu
05:43
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The NICHE-3 Study on Neoadjuvant Nivo + Re…

Feat. Y. Verschoor
14:54
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…

Feat. L. Rimassa
14:33
Insights from 2023 ESMO Annual Meeting

Personalized Medicine and Targeted Agents for Biliary Tract Cancer

Feat. L. Rimassa
17:05
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "A Multicenter, Randomized, Open-Label, Thr…

Feat. A. Ohba
06:24
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Tinengotinib in Pts With Advanced, FGFR In…

Feat. M. Pelster
08:55
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Adagrasib +/- Cetuximab in Patients With K…

Feat. M. Pelster
03:50
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Post Hoc Analysis of the ABC-01, -02 and -…

Feat. A. Lamarca
10:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Randomized Phase 3 GASTFOX Study - 5-fluor…

Feat. A. Zaanan